Document is current
Any future updates will be listed below
-
Authors
Bernareggi, Davide
Xie, Qi
Prager, Briana C.
Yun, Jiyoung
Cruz, Luisjesus S.
Pham, Timothy V.
Kim, William
Lee, Xiqing https://orcid.org/0000-0001-9176-736X
Coffey, Michael https://orcid.org/0000-0002-8025-4558
Zalfa, Cristina
Azmoon, Pardis https://orcid.org/0000-0002-1512-5581
Zhu, Huang
Tamayo, Pablo
Rich, Jeremy N.
Kaufman, Dan S. https://orcid.org/0000-0002-2003-2494
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U24CA220341, CA197718, U01CA217885)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 22 March 2021
Accepted: 9 March 2022
First Online: 7 April 2022
Competing interests
: D.S.K. is a co-founder and advisor to Shoreline Biosciences and has an equity interest in the company. D.S.K. also consults for Qihan Biotech and VisiCELL Medical for which he receives income and/or equity. Studies in this work are not related to the work of those companies. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.
